
Lomir2.5 mg
Novartis (Bangladesh) Ltd.
Isradipine is indicated for the treatment of hypertension (high blood pressure).
Isradipine is indicated for the treatment of hypertension (high blood pressure). It may be used alone or in combination with other antihypertensive agents, most commonly a thiazide diuretic, when a single agent does not adequately control blood pressure.
Isradipine is not approved for the treatment of acute hypertensive emergencies or angina.
| Formulation | Starting Dose | Titration | Maximum Dose |
|---|---|---|---|
| Immediate-release capsules | 2.5 mg twice daily | May increase by 5 mg/day at 2-4 week intervals | 20 mg/day (little added benefit typically seen above 10 mg/day, with increased side effects) |
| Controlled-release (CR) tablets | 5 mg once daily | May increase at 2-4 week intervals | 20 mg once daily |
Isradipine should be taken consistently, either with or without food, as directed by the physician, and should not be discontinued abruptly without medical advice.
Common side effects of Isradipine are generally related to its vasodilatory action and are often dose-dependent:
Less commonly, Isradipine may cause symptomatic hypotension, and rarely, worsening of angina symptoms may occur at the start of therapy or with dose increases (see Precautions and Warnings). Patients should report persistent or severe side effects to their physician.
Isradipine is contraindicated in patients with known hypersensitivity to Isradipine or any component of the formulation.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.